Long-COVID is a complex post-infection condition defined by symptoms that
persist after an acute SARS-CoV-2 infection. These may include newly emerging
symptoms or symptoms that persist and occur during recovery and result from the
primary SARS-CoV-2 infection. This paper provides a synopsis of what is currently
known about long-COVID using a summary of the last several years' literature.
Specifically, focus is put on the variability of symptomatology, multiple organ
system involvement, as well as the impact on the patient's functional status and
overall quality of life. This review also describes the possible mechanisms involved
in the persistence of symptoms, including viral persistence, immune system
dysfunction, and mechanisms similar to those observed in myalgic
encephalomyelitis/chronic fatigue syndrome. Additionally, this paper assesses
existing treatment options and digital therapies for long-COVID symptoms,
acknowledges the lack of evidence-based treatments for these patients, and
identifies populations that may be at increased risk of long-term complications
following SARS-CoV-2 infection. Finally, the entire review shows the heterogeneity
of long-COVID and draws attention to the need for future studies to improve our
knowledge of the biological mechanisms involved in this condition, as well as to
develop evidence-based treatment options.
Keywords: Long COVID; post-COVID syndrome; post-acute sequelae of SARSCoV-
2 infection (PASC); SARS-CoV-2; post-viral fatigue
